Inflammatory Bowel Disease (IBD)

New and Updated Resources - December 2018


(For Gastroenterologists)
(For GPs and Obstetricians)
(For Patients)

Clinical Update for General Practitioners and Physicians - Inflammatory Bowel Disease 4th Edition (2018 Update)

Inflammatory Bowel Disease (IBD) is a general diagnostic term that describes conditions with idiopathic, chronic, relapsing and remitting inflammation of the gastrointestinal tract. Crohn’s Disease (CD) and Ulcerative Colitis (UC) are the two most common types of IBD. UC is limited to the colon (large intestine).

This revised document (2018 update) is a general guide to appropriate practice, to be followed subject to the clinician's judgement and the patient's preference in each individual case in the management of Inflammatory Bowel Disease. The clinical update is designed to provide information to assist in decision making but is not exhaustive, nor does it cover every discrete situation.

It is based on the best evidence available at the time of writing. 

The document is intended primarily for the use of clinicians in Australia, while complementing recent consensus statements published by the European Crohn's and Colitis Organisation (ECCO), the British Society of Gastroenterology and other international organisations.

Every effort has been made to check drug dosage recommendations in this clinical update but it is still possible that inaccuracies exist. Furthermore, dosage recommendations are continually being revised and new adverse events recognised. Trade names used in this publication are for identification purposes only. Their use does not imply endorsement of any particular brand of drug.

The document has been prepared by the Gastroenterological Society of Australia and every care has been taken in its development. The Gastroenterological Society of Australia and other compilers of this clinical update do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information.


Consensus Statements on Therapeutic Drug Monitoring of Anti-tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases

A wall chart for medical practitioners outlining algorithms for the interpretation of TDM results may be downloaded here

Review Article by N. Mitrev et al - published in AP&T Alimentary Pharmacology &Therapeutics, 2017.


Consensus Statements on Acute Severe Ulcerative Colitis

A wall chart for medical practitioners on the management of Acute Severe Ulcerative Colitis may be downloaded here

Review Article by J.H. Chen et al - published in AP&T Alimentary Pharmacology &Therapeutics, 2016.